CDI Seminar: “Lesion-centric PK/PD Considerations for TB Drug Discovery and Regimen Design”
Title: “Lesion-centric PK/PD Considerations for TB Drug Discovery and Regimen Design”
Speaker:
Jansy Sarathy, PhD
Assistant Member of the Center for Discovery and Innovation HMH
Assistant Professor at the Hackensack Meridian School of Medicine
Location:
Via Zoom (Meeting ID: 872 2523 0702)
About the Speaker:
I graduated from National University of Singapore, School of Medicine after the completion of a graduate research program at the Novartis Institute for Tropical Diseases. I was a postdoctoral research fellow at the Public Health Research Institute, Rutgers, where I trained under veteran TB pharmacologist Dr. Veronique Dartois. I then pursued a faculty position at the Center for Discovery and Innovation. My research focuses on applying site-of-disease pharmacokinetic-pharmacodynamic (PK-PD) concepts to provide pharmacological rationale for TB treatment efficacy. View full bio.